Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Abstract

The interaction of the beta-anomer of doxorubicin with B and Z DNA.

M Britt, F Zunino and J B Chaires
Molecular Pharmacology January 1986, 29 (1) 74-80;
M Britt
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
F Zunino
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J B Chaires
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

Equilibrium and kinetic studies on the interaction of daunorubicin, doxorubicin, and the beta-anomer of doxorubicin with B and Z form DNA were made using spectroscopic and fluorometric methods. The beta-anomer of doxorubicin binds more weakly to calf thymus DNA than do the parent compounds, with a binding constant over 2 orders of magnitude lower than that found for doxorubicin. The ionic strength dependence of the binding constant is identical for daunorubicin and the beta-anomer of doxorubicin, indicating that the electrostatic contribution to the binding free energy is the same for the two compounds. Rate constants for steps along the dissociation pathway are larger for the beta-anomer relative to the parent compounds, indicating a shorter lifetime for the beta-anomer-DNA complex. Daunorubicin and doxorubicin were equally effective as inhibitors of the rate of the B to Z transition of polydeoxyguanylic-deoxycytidylic acid (poly(dGdC] in 3.0 M NaCl. Both compounds bound cooperatively to poly (dGdC) under high salt conditions that initially favor the Z conformation. In contrast, the beta-anomer of doxorubicin did not inhibit the rate of the B to Z transition under these conditions, and would not bind to poly(dGdC) in 3.0 M NaCl. The beta-anomer did inhibit the rate of the transition of poly(dGm5dC) to the Z form in 50 mM NaCl, 2.5 mM MgCl2, although not as effectively as daunorubicin. Further, binding of the beta-anomer to poly(dGm5dC) under these conditions was cooperative, although the beta-anomer was clearly a less efficient allosteric effector on the B to Z transition than was daunorubicin. These results emphasize the importance of the stereochemistry of the daunosamine residue in the specific and preferential binding of anthracycline antibiotics to B form DNA.

MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Molecular Pharmacology
Vol. 29, Issue 1
1 Jan 1986
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
The interaction of the beta-anomer of doxorubicin with B and Z DNA.
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Abstract

The interaction of the beta-anomer of doxorubicin with B and Z DNA.

M Britt, F Zunino and J B Chaires
Molecular Pharmacology January 1, 1986, 29 (1) 74-80;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Abstract

The interaction of the beta-anomer of doxorubicin with B and Z DNA.

M Britt, F Zunino and J B Chaires
Molecular Pharmacology January 1, 1986, 29 (1) 74-80;
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics